Business
Holding in Company
Holding in Company.
About this update from Genflow Biosciences Plc
[{"type":"text","content":"\n\n \n \n\n1. Issuer Details\n\n\n\nISIN\n\n\nGB00BP2C3V08\n\n\nIssuer Name\n\n\nGENFLOW BIOSCIENCES PLC\n\n\nUK or Non-UK Issuer\n\n\nUK\n\n\n\n2. Reason for Notification\n\n\nAn acquisition or disposal of voting rights\n\n\n3. Details of person subject to the notification obligation\n\n\n\nName\n\n\nMR ERIC LEIRE\n\n\nCity of registered office (if applicable)\n\n\n15 Ingestre Place,\n\n\nCountry of registered office (if applicable)\n\n\nUK\n\n\n\n\n\n\nName\n\n\nCity of registered office\n\n\nCountry of registered office\n\n\n\n\nEric Leire\n\n\n\n\n\n\n\n\n\n\n\n\n\n4. Details of the shareholder\n\n\n\nFull name of shareholder(s) if different from the person(s) subject to the notification obligation, above\n\n\n \n\n\nCity of registered office (if applicable)\n\n\n \n\n\nCountry of registered office (if applicable)\n\n\n \n\n\n\n5. Date on which the threshold was crossed or reached\n\n\n27-Mar-2025\n\n\n6. Date on which Issuer notified\n\n\n27-Mar-2025\n\n\n7. Total positions of person(s) subject to the notification obligation\n\n\n\n\n\n\n\n\n% of voting rights attached to shares (total of 8.A)\n\n\n% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)\n\n\nTotal of both in % (8.A + 8.B)\n\n\nTotal number of voting rights held in issuer\n\n\n\n\nResulting situation on the date on which threshold was crossed or reached\n\n\n36.180000\n\n\n0.000000\n\n\n36.180000\n\n\n126514999\n\n\n\n\nPosition of previous notification (if applicable)\n\n\n35.600000\n\n\n0.000000\n\n\n35.600000\n\n\n\n\n\n\n\n\n8. Notified details of the resulting situation on the date on which the threshold was crossed or reached\n\n\n8A. Voting rights attached to shares\n\n\n\n\n\n\nClass/Type of shares ISIN code(if possible)\n\n\nNumber of direct voting rights (DTR5.1)\n\n\nNumber of indirect voting rights (DTR5.2.1)\n\n\n% of direct voting rights (DTR5.1)\n\n\n% of indirect voting rights (DTR5.2.1)\n\n\n\n\nGB00BP2C3V08\n\n\n126514999\n\n\n\n\n\n36.180000\n\n\n\n\n\n\n\nSub Total 8.A\n\n\n126514999\n\n\n36.180000%\n\n\n\n\n\n\n8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))\n\n\n\n\n\n\nType of financial instrument\n\n\nExpiration date\n\n\nExercise/conversion period\n\n\nNumber of voting rights that may be acquired if the instrument is exercised/converted\n\n\n% of voting rights\n\n\n\n\n \n\...